Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MC Dinasty (Beijing) Biotechnology Co., Ltd. is a specialized biotechnology firm headquartered in Beijing, China, focusing on the in vitro diagnostics (IVD) sector. The company primarily develops, manufactures, and markets molecular diagnostic systems and point-of-care testing (POCT) solutions. Its core product portfolio includes automated nucleic acid extraction instruments and real-time PCR systems, complemented by a wide array of diagnostic reagent kits. These products are designed to detect various pathogens, including those responsible for respiratory, gastrointestinal, and sexually transmitted infections. MC Dinasty's technology platform emphasizes high sensitivity, automation, and rapid turnaround times for clinical laboratories and healthcare providers. The company maintains ISO 13485 certification and serves both domestic and international markets with its diagnostic innovations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MC Dinasty.